San Diego, CA, United States of America

Michael Gallaspy

This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Illumina Corporation. Active years: 2025.


% Patents Active = 100.0

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Michael Gallaspy

Introduction

Michael Gallaspy is a prominent inventor based in San Diego, California. He has made significant contributions to the field of artificial intelligence and genetic sequencing. His work focuses on enhancing the accuracy and efficiency of sequencing images, which is crucial for advancements in genetic research.

Latest Patents

Gallaspy holds a patent for an innovative technology titled "AI-driven enhancement of motion blurred sequencing images." This invention utilizes artificial intelligence to improve the performance, accuracy, and cost-effectiveness of genetic sequencing. By training a neural network with a set of images taken during different movement settling times, Gallaspy's technology can recover enhanced images from unenhanced ones, thereby facilitating better sequencing results.

Career Highlights

Michael Gallaspy is currently associated with Illumina Corporation, a leading company in the field of genomics. His role at Illumina allows him to work on cutting-edge technologies that push the boundaries of genetic research. His expertise in artificial intelligence and image processing has positioned him as a valuable asset in the industry.

Collaborations

Due to space constraints, the details of Gallaspy's collaborations will not be included.

Conclusion

Michael Gallaspy's innovative work in AI-driven genetic sequencing represents a significant advancement in the field. His contributions are paving the way for more accurate and efficient genetic research, which has the potential to impact various areas of science and medicine.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…